Is Menopausal Hormone Therapy Risky for Your Heart?

Published: Feb 02, 2024

Menopausal hormone therapy (MHT) can ease menopause symptoms, but how does it affect your heart? Let's explore the potential cardiovascular risks associated with MHT.
Contents

Hormone Therapy and Heart Disease

Initially, it was believed that MHT could help prevent heart disease, but large studies like the Women's Health Initiative (WHI) showed otherwise. The research found that MHT did not protect against heart disease and might even increase the risk, especially in older women. Factors such as age, hormone type, and timing of therapy play crucial roles in determining heart health risks associated with MHT.

Age and Timing Matter

The 'timing hypothesis' suggests that starting MHT closer to menopause might be safer for the heart than beginning it later. Younger women on MHT showed fewer heart issues compared to older women who started MHT long after menopause. This indicates that the timing of hormone exposure is key in evaluating heart risks.
Investigating the potential cardiovascular risks of menopausal hormone therapy, including the impact of age, hormone type, and timing on heart health.

Estrogen and Progestin Effects

Estrogen alone may pose less heart risk compared to combined estrogen-progestin therapy. Studies show that adding progestin can increase the risk of heart disease. The type of progestin used might influence these outcomes, with some forms being more harmful than others.

Frequently Asked Questions

No, MHT does not prevent heart disease and might increase the risk.

Estrogen alone may be less risky than combined therapy with progestin.

It suggests starting MHT soon after menopause might be safer for the heart.

Yes, older women face higher heart risks with MHT.

The Heart of the Matter

Understanding the timing and type of MHT is crucial to managing heart health risks.
Talk with Doctronic about how MHT might impact your heart health today.

Related Articles

References

  1. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321.
  2. Grodstein F, Manson JE, Stampfer MJ. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health (Larchmt) 2006; 15:35.

This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.

AI Doctor Visit Required

Appointments available 24/7

😀 😀 😀
stethoscope

Top licensed doctors

Available in all 50 states

dossier

Full service care

Prescriptions, referrals & treatment

check

No insurance needed

All notes available in Doctronic

15-min consultation. No hidden costs.

AI Doctor Visit Required
Close icon

Please Chat With Our AI Doctor First

Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care

Lifebuoy

For safety reasons we have been forced to end this consultation.

If you believe this is a medical emergency please call 911 or your local emergency services immediately.

If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.

Contact us

You can also email us at help@doctronic.ai

We aim to reply within 5-7 days

How likely are you to recommend Doctronic to friends or family?
Not likely at all Extremely likely